Dave McLean, CEO, Emerging Therapy Solutions is participating in a panel session on Thursday, November 18, 2021 at 1pm-3pm CT.
Session Title: Cellular Immunotherapy Reimbursement: Challenges and opportunities
- How do you measure value?
- What is the value for manufacturers, patients, society, and providers?
- How can data inform financial models?
About the Forum
ASTCT™, the CIBMTR® and the National Marrow Donor Program®(NMDP)/Be The Match® are excited to present the AcCELLerate Forum: Creating a Sustainable Ecosystem of Cell and Gene Therapy—a two-day, virtual workshop offering providers, payers, government agencies, and industry involved in the field of cell and gene therapy increased educational and advocacy opportunities. This new workshop, scheduled for November 18-19, 2021, features educational sessions bridging the gap among stakeholders, and identify ongoing needs and opportunities in the field for advocacy, measurement of value and impact, and sustainability.
For more on the forum, visit https://www.astct.org/attend/accellerate-forum